Embassy Developments DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.97×0.97×7.09×1.02×1.08×
1.50×1.72×0.18×2.33×1.01×
−51.4%−30.1%6.8%−106.2%−95.1%
0.08×0.08×0.17×0.07×0.09×
2.16×2.16×2.20×2.11×1.77×
−12.9%−8.7%3.3%−37.1%−16.5%
−9.1%−9.1%3.4%−32.4%−17.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

EMBDL₹48.70

Embassy Developments Ltd.

· Real Estate
₹ CrorePeersPRESTIGEBRIGADESOBHADBREALTYLOTUSDEVPURVASUNTECKTARCMcap ₹6,769 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×1.081.027.090.970.97
Interest Burden (Pretax/EBIT) ×1.012.330.181.721.50
EBIT Margin %-95.09-106.196.84-30.11-51.44
Asset Turnover ×0.090.070.170.080.08
Financial Leverage (Assets/Equity) ×1.772.112.202.162.16
ROE (5-step product, year-end total equity) %-16.54-37.143.32-8.71-12.91
ROE (owners' profit / average owners' equity) %-17.18-32.403.42-9.10-9.10
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.